China SXT Pharmaceuticals, Inc. (SXTC) NASDAQ

Currency In USD

AD

Valuation

Market Cap91.34M
Enterprise Value64.28M
P/E Ratio-0
PEG Ratio0
Price/Sales Ratio0.01
Price/Book Ratio0
Enterprise/Revenue-25.21
Enterprise/EBITDA3.87

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-5.78
Operating Margin-9.96
AD

Management Effectiveness

Return On Assets-0.18
Return On Equity-0.25

Income Statement

Revenue1.07M
Revenue/Share183.11
Gross Profit183,282
EBITDA-6.98M
Net Income-6.21M
Diluted EPS-913

Balance Sheet

Total Cash28.18M
Total Cash/Share4,809.87
Total Debt1.12M
Total Debt/Equity0.04
Current Ratio7.93
Book Value Per Share5,071.26

Price History

52-Week Change-100
52-Week High8.38M
52-Week Low2.71
Moving Average 50 Days133
Moving Average 200 Days12,148.78

Statistics

Average Volume229,837
Shares Outstanding5,340
% Held by Institutions0

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:100
Last Split DateOctober 26, 2026
AD